Used as a key intermediate in the synthesis of pharmaceutical agents targeting neurological disorders, such as depression, anxiety, or certain psychotic conditions, particularly those involving specific receptors in the brain related to neurotransmitter function.

Its structure features a fluorine group and heterocyclic rings (pyrazole and pyridine), enabling good blood-brain barrier penetration, making it suitable for developing central nervous system (CNS) therapeutics. The chiral amine moiety allows for selective binding to enzyme active sites, enhancing drug efficacy and reducing off-target effects.

Commonly employed in the preparation of small-molecule therapeutics with improved metabolic stability and bioavailability. Also utilized in medicinal chemistry research for structure-activity relationship (SAR) studies to design novel drugs with high specificity and minimal side effects.